Earlier in June 2026, the US Food and Drug Administration posted a Class II, firm-initiated recall of 9,750 Boston Scientific ...

NATICK, Mass., European regulators have approved an expanded indication for the Boston Scientific Corporation WATCHMAN ® Left Atrial Appendage (LAA) Closure Device. The new indication offers patients ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

BTIG analysts remain high on Boston Scientific (NYSE:BSX) following meetings with the company's management this week.

Boston Scietific's Watchman left atrial appendage closure (LAAC) device won FDA approval in 2015 after an unprecendented three FDA panel reviews. Since then, the Watchman device has become one of the ...

MARLBOROUGH, Boston Scientific today announced that the first implants of the WATCHMAN FLX ™ Left Atrial Appendage Closure (LAAC) Device – the latest generation of the WATCHMAN Device – occurred in ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Boston Scientific (BSX) stock has been under pressure ...

On Friday, Boston Scientific announced that FDA has approved the Watchman left atrial appendage closure device, a heart device that while novel was initially rejected. The device is intended for ...

Shares of Boston Scientific (BSX) lost ~10% in the morning hours on Wednesday to hit a 52-week low after the MedTech highlighted an ongoing slowdown in demand for its WATCHMAN cardiac implant. With ...

MARLBOROUGH, Mass., March 13, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) announced it has received CE Mark and initiated a limited market release of the next generation WATCHMAN ...